|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||70.18 - 72.95|
|52 Week Range||59.60 - 85.92|
|PE Ratio (TTM)||95.84|
|Earnings Date||Jul 16, 2018 - Jul 20, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||80.50|
Medidata Solutions Inc (NASDAQ:MDSO), a healthcare services company based in United States, saw a double-digit share price rise of over 10% in the past couple of months on the NasdaqGS.Read More...
The New York-based company said it had profit of 17 cents per share. Earnings, adjusted for one-time gains and costs, were 40 cents per share. The results beat Wall Street expectations. The average estimate ...
NEW YORK, NY / ACCESSWIRE / April 19, 2018 / Medidata Solutions, Inc. (NASDAQ: MDSO ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 19, 2018 at 8:00 AM Eastern ...
Medidata , the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its first quarter 2018 financial results before the open of the market on Thursday, April 19, 2018.
Medidata announced that the National Health and Medical Research Council Clinical Trial Centre , University of Sydney, will now use Medidata’s unified platform and analytics for all major new studies starting in 2018.
Medidata successfully hosted NEXT conferences in Basel and Frankfurt, with executives from global life sciences and pharmaceutical companies presenting, including Bayer, Cancer Research UK, and Roche.
Oncology is leading the precision medicine revolution, as clinical researchers leverage and identify biomarkers to target patient subsets with more effective treatments, and the promise of improving Phase I success rate probability by three times 1.
Stock Monitor: Medical Transcription Billing Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 15, 2018 / Active-Investors.com has just released a free earnings report on Medidata Solutions, Inc. ...
Medidata today announced that Tarek Sherif, chief executive officer, and Rouven Bergmann, chief financial officer, will present at the Morgan Stanley Technology, Media & Telecom Conference on Wednesday, February 28, 2018, at 11:15 a.m.
Santen Pharmaceutical Co., Ltd, is expanding its use of the Medidata Clinical Cloud® with the adoption of Edge CTMS to support its clinical trial operations, in ophthalmology, across Japan, Asia, USA and the EU.
Medidata today announced that eClinical Solutions LLC, an industry-leading provider of end-to-end data management services and cloud based products for clinical data optimization, is expanding their technology partnership to further improve clinical trial processes and help life sciences researchers deliver innovative therapies to patients with the adoption of Rave Imaging.
Medidata has been named to Barron’s first annual list of the “100 Most Sustainable Companies” in the U.S., demonstrating the company's positive impact in five categories: shareholders, employees, customers, community and planet.
Aperio, a leading clinical research organization formerly known as iNNO Clinical Outcomes, has expanded its use of the Medidata Clinical Cloud ® platform to include Edge eTMF and Edge CTMS, Medidata announced today.
As clinical trials become more complex, sponsors and contract research organizations are looking for a unified platform to help them overcome challenges such as dealing with disparate systems, complying with new regulatory requirements and managing an increasing variety and volume of data.
NEW YORK, Feb. 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Penske ...
Medidata Solutions , is pleased to announce the 13th annual NEXT Conference series will commence in Europe in March 2018, with events in Basel , Frankfurt and London .
Medidata Solutions Inc (NASDAQ:MDSO) trades with a trailing P/E of 90.1x, which is higher than the industry average of 44.6x. While this makes MDSO appear like a stock to avoidRead More...
The New York-based company said it had profit of 23 cents per share. Earnings, adjusted for one-time gains and costs, came to 41 cents per share. The results surpassed Wall Street expectations. The average ...
Medidata announced today that its virtual trials platform, Engage, is now being offered as a part of the Medidata Clinical Cloud®, providing researchers unmatched flexibility to conduct clinical trials virtually, on-site, or as a hybrid.